Crohn's Disease and Colitis Trial, Recruiting NCT05903066 Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT05903066
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed with Crohn's disease for more than 6 months, with confirmation from tissue testing recorded in their medical file
  • People whose treating doctor has determined that an MRI scan of the bowel (called MRE) is needed as part of their normal care
  • People currently on any type of Crohn's disease treatment, including biologics (such as infliximab, adalimumab, vedolizumab, or ustekinumab) or immunosuppressant medications (such as azathioprine, 6-mercaptopurine, or methotrexate)
  • People who have signed and dated a written consent form before the study begins
  • People who fit into a participant category that the trial still has space for (the trial site will assess this)

Who may not be able to join:

  • People who are pregnant during the study
  • People who are unable to give consent due to their physical or mental condition
  • People who have not provided written consent
  • People diagnosed with ulcerative colitis or a type of inflammatory bowel disease that has not been clearly classified
  • People who have had certain bowel surgeries, such as an ileoanal anastomosis, ileostomy, or colostomy
  • People with fewer than 3 assessable bowel segments, or more than 3 surgically removed bowel segments (not counting the ileocecal valve) (confirm with trial site)
  • People with severe symptoms of bowel blockage
  • People with an active, symptomatic abscess inside the abdomen
  • People for whom an MRI scan is not medically safe
  • People whose Crohn's disease affects only the area around the anus, with no involvement of the digestive tract itself
  • People whose MRI bowel scan images are of insufficient quality based on the trial's defined standards

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sophie GEYL, CHU Limoge Dupuytren

Phone: +33 5 55 05 66 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Registry
ClinicalTrials.gov
Start date
28 September 2023
Est. completion
1 July 2025

Where this trial is recruiting

🇧🇪 Belgium 🇫🇷 France

Primary endpoints

Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov